As an important regulator of triglyceride hydrolysis and fatty acid metabolism, the lipid metabolism-related enzyme LIPK (Lipase K) may disrupt lipid homeostasis, affecting the energy supply, membrane structure remodeling, and signal transduction of tumor cells, thereby driving the progression of lung adenocarcinoma (20–22). The gene discussed is LIPK; the disease is neoplasm.